MEDIUM confidence: 95% data completeness, but the composite (37) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 4 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $2.6B— | $2.6B+2.7% | $3.5B+34.1% |
| EPS (dil.) | $0.12— | $0.36+200.0% | $0.20-44.4% |
| Free Cash Flow | $262M— | -$10M-103.9% | $440Mn/m |
| Gross Margin | 36.7% | 38.4%+1.7pp | 38.8%+0.4pp |
| Operating Margin | 16.4% | 18.5%+2.2pp | 14.3%-4.3pp |
| Net Margin | 2.3% | 6.7%+4.4pp | 0.9%-5.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider $219.6M over 180 days (2 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $38 avg across 3 analysts.
Buy-rated share 75% → 82% over ~3 months (+7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.24 | $0.31 | +27.5% |
| May 2026 | $0.00 | $830.88 | +60559666.8% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 7.6%/yr (revenue basis).
Base free cash flow $231M (avg FY2023–FY2025; latest year $440M) · equity value $11.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 37 for MAIR suggests a neutral outlook, driven by a high growth score of 71, which is offset by low value and risk scores of 28 and 20, respectively. The stock trades at a premium, with a P/E of 105.9, while exhibiting strong revenue growth of 34.1% and significant free cash flow growth of 4369.9%. However, its momentum score is dragged down by a 3-month return of -20.6% and a bearish moving average trend, indicating recent weakness.